(Q51009769)

English

Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.

scientific article published on 10 February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

based on heuristic

inferred from title

pancreatic adenocarcinoma

1 reference

based on heuristic

inferred from title

Jean Robert Delpero

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jean-Marie Boher

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Antonio Sa Cunha

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Yves Patrice Le Treut

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jean Yves Mabrut

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Laurence Chiche

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Olivier Turrini

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Philippe Bachellier

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

François Paye

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

10 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1874-1883

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25665947%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

https://scigraph.springernature.com/pub.10.1245/s10434-014-4304-3

0 references

National failure to operate on early stage pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Pancreatic surgery for adenocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Pancreaticoduodenectomy with vascular resection: margin status and survival duration

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Portal vein resection during pancreaticoduodenectomy for cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Aggressive surgery for borderline resectable pancreatic cancer: evaluation of National Comprehensive Cancer Network guidelines

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Pancreaticoduodenectomy combined with vascular resection and reconstruction for patients with locally advanced pancreatic cancer: a multicenter, retrospective analysis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Current practice patterns in pancreatic surgery: results of a multi-institutional analysis of seven large surgical departments in Germany with 1454 pancreatic head resections, 1999 to 2004 (German Advanced Surgical Treatment study group).

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Defining venous involvement in borderline resectable pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Hospital volume and surgical mortality in the United States.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Perioperative mortality for pancreatectomy: a national perspective

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Effect of surgeon volume on outcome following pancreaticoduodenectomy in a high-volume hospital

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Clinical and pathologic features influencing survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Pancreatic cancer surgery in the new millennium: better prediction of outcome

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Redefining the R1 resection in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Standardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 Trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma?

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Most Pancreatic Cancer Resections are R1 Resections

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-4304-3

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51009769&oldid=1525674943"